Susan M Chang, MD
Neurological Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
Offices
1 location
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (415) 353-2966 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A50785 · Current
Licensed to practise in California · since 1992 · expires 2028-01-31 · University of British Columbia Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 22 Part D prescriptions in 2019. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2019 | 22 | None | 0% (0) | 0% | $803 |
| 2018 | 21 | None | 0% (0) | 0% | $526 |
| 2017 | 42 | 11 | 0% (0) | None | $1,237 |
| 2016 | 123 | 18 | None | 15% | $6,374 |
| 2015 | 146 | 22 | 0% (0) | 14% | $7,121 |
| 2014 | 145 | 23 | 0% (0) | None | $7,976 |
| 2013 | 147 | 17 | None | None | $6,684 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Levetiracetam | 12 | $358 | $30 |
2018: 1 drug
| Levetiracetam | 11 | $190 | $17 |
2017: 1 drug
| Dexamethasone | 13 | $262 | $20 |
2016: 3 drugs
| Levetiracetam Er | 11 | $717 | $65 |
| Dexamethasone | 16 | $461 | $29 |
| Levetiracetam | 27 | $417 | $15 |
2015: 3 drugs
| Levetiracetam Er | 13 | $1,054 | $81 |
| Levetiracetam | 60 | $995 | $17 |
| Dexamethasone | 12 | $422 | $35 |
2014: 4 drugs
| Carbamazepine Er | 12 | $1,685 | $140 |
| Dexamethasone | 24 | $672 | $28 |
| Levetiracetam | 22 | $507 | $23 |
| Ondansetron | 19 | $220 | $12 |
2013: 4 drugs
| Carbamazepine Er | 12 | $1,573 | $131 |
| Keppra Xr | 12 | $873 | $73 |
| Levetiracetam | 21 | $791 | $38 |
| Lisinopril | 17 | $70 | $4 |
Money from drug and device companies
$31 in 2025
| 2025 | 1 | 1 | None | $31 |
| 2024 | 1 | 9 | None | $181 |
| 2023 | 3 | 11 | None | $488 |
| 2022 | 1 | 1 | None | $130 |
| 2021 | 1 | 1 | $77 | $77 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $31 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-07-14 | Ubrelvy | $31 |
See earlier years (2024, 2023, 2022, 2021)
2024: $181
| Abbvie | Qulipta | $181 | 9 payments
|
2023: $488
| AbbVie | Qulipta | $243 | 9 payments
|
| Stryker | Adherus Autospray Et Dural Sealant | $170 | 1 payment
|
| Merz North America | Xeomin | $75 | 1 payment
|
2022: $130
| Axonics | Axonics | $130 | 1 payment
|
2021: $77
| Servier Pharmaceuticals | Tibsovo | $77 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Agios Pharmaceuticals, Inc. · Tibsovo · 2019 | Their institution | $24,660 |
| Agios Pharmaceuticals, Inc. · Single Cell Analysis of Cohort 2 of Glioma Perioperative Patients Ag120-881-C-001 · 2019 | Their institution | $24,660 |
| Agios Pharmaceuticals, Inc. · Sponsored Research Agreement · 2019 | Their institution | $4,070 |
Professional record
- NPI
- 1346299518
- Licence
- CA A50785California A50785: Current · expires 2028-01-31
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A507850
- Taxonomy
- Federal specialty code 207T00000X (207T00000X)
- Mailing address
- 1635 Divisadero St, Ste. 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-05-08
- NPI last updated
- 2008-06-16
This is when the NPI record was last certified, not a medical board exam.